1. Home
  2. CGEM vs ARQQ Comparison

CGEM vs ARQQ Comparison

Compare CGEM & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ARQQ
  • Stock Information
  • Founded
  • CGEM 2016
  • ARQQ 2017
  • Country
  • CGEM United States
  • ARQQ United Kingdom
  • Employees
  • CGEM N/A
  • ARQQ N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ARQQ Computer Software: Prepackaged Software
  • Sector
  • CGEM Health Care
  • ARQQ Technology
  • Exchange
  • CGEM Nasdaq
  • ARQQ Nasdaq
  • Market Cap
  • CGEM 482.7M
  • ARQQ 531.6M
  • IPO Year
  • CGEM 2021
  • ARQQ N/A
  • Fundamental
  • Price
  • CGEM $8.19
  • ARQQ $30.81
  • Analyst Decision
  • CGEM Strong Buy
  • ARQQ Strong Buy
  • Analyst Count
  • CGEM 7
  • ARQQ 1
  • Target Price
  • CGEM $26.57
  • ARQQ $52.00
  • AVG Volume (30 Days)
  • CGEM 364.2K
  • ARQQ 421.6K
  • Earning Date
  • CGEM 08-07-2025
  • ARQQ 05-22-2025
  • Dividend Yield
  • CGEM N/A
  • ARQQ N/A
  • EPS Growth
  • CGEM N/A
  • ARQQ N/A
  • EPS
  • CGEM N/A
  • ARQQ 0.48
  • Revenue
  • CGEM N/A
  • ARQQ $241,000.00
  • Revenue This Year
  • CGEM N/A
  • ARQQ $284.30
  • Revenue Next Year
  • CGEM N/A
  • ARQQ $415.45
  • P/E Ratio
  • CGEM N/A
  • ARQQ $63.61
  • Revenue Growth
  • CGEM N/A
  • ARQQ N/A
  • 52 Week Low
  • CGEM $6.85
  • ARQQ $3.72
  • 52 Week High
  • CGEM $19.89
  • ARQQ $52.79
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 56.95
  • ARQQ 43.27
  • Support Level
  • CGEM $6.89
  • ARQQ $27.29
  • Resistance Level
  • CGEM $8.08
  • ARQQ $35.50
  • Average True Range (ATR)
  • CGEM 0.40
  • ARQQ 2.34
  • MACD
  • CGEM 0.05
  • ARQQ -0.51
  • Stochastic Oscillator
  • CGEM 92.20
  • ARQQ 33.43

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

Share on Social Networks: